Ja. Puma et al., Support for the open-artery hypothesis in survivors of acute myocardial infarction: Analysis of 11,228 patients treated with thrombolytic therapy, AM J CARD, 83(4), 1999, pp. 482-487
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
We examined the possible benefits of achieving and maintaining infarct-rela
ted artery potency beyond the time when preservation of left ventricular fu
nction would be expected. The open-artery hypothesis suggests that a patent
infarct-related artery confers a survival benefit greater than that expect
ed from myocardial salvage alone, which extends beyond the time when preser
vation of left ventricular function is expected. We examined the survival e
xperience of patients undergoing thrombolysis in the Global Utilization of
Streptokinase and TPA for Occluded Arteries (GUSTO-I) trial for whom data o
n the potency of the infarct artery were available. Univariable analysis wa
s used to determine the unadjusted relations of angiographic variables and
revascularization procedures to both 30-day and 1-year mortality in 30-day
survivors. Multivariable analysis was used to test far interactions between
patency and each characteristic and to adjust both for all other variables
and for baseline characteristics known to predict mortality, In both univa
riable and multivariable analysis, patients with an open rather than a clos
ed infarct-related artery had significantly lower 30-day mortality (p <0.00
1), This benefit cannot be accounted for by myocardial salvage alone, becau
se it remained after adjustment for left ventricular ejection fraction. Pat
ency was also associated with lower 1-year mortality in 30-day survivors, b
ut not after adjustment for other variables affecting late mortality. Havin
g an open infarct-related artery at the time of first catheterization confe
rs a survival advantage that extends beyond the benefit of myocardial salva
ge from thrombolytic therapy, and is independent of election fraction. (C)
1999 by Excerpta Medico, Inc.